Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticleBrain

Evaluation of Parkinson Disease and Alzheimer Disease with the Use of Neuromelanin MR Imaging and 123I-Metaiodobenzylguanidine Scintigraphy

F. Miyoshi, T. Ogawa, S.-i. Kitao, M. Kitayama, Y. Shinohara, M. Takasugi, S. Fujii and T. Kaminou
American Journal of Neuroradiology November 2013, 34 (11) 2113-2118; DOI: https://doi.org/10.3174/ajnr.A3567
F. Miyoshi
aFrom the Division of Radiology (F.M., T.O., S.-i.K., Y.S., M.T., S.F., T.K.), Department of Pathophysiological Therapeutic Science
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Ogawa
aFrom the Division of Radiology (F.M., T.O., S.-i.K., Y.S., M.T., S.F., T.K.), Department of Pathophysiological Therapeutic Science
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S.-i. Kitao
aFrom the Division of Radiology (F.M., T.O., S.-i.K., Y.S., M.T., S.F., T.K.), Department of Pathophysiological Therapeutic Science
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Kitayama
bDivision of Neurology (M.K.), Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Shinohara
aFrom the Division of Radiology (F.M., T.O., S.-i.K., Y.S., M.T., S.F., T.K.), Department of Pathophysiological Therapeutic Science
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Takasugi
aFrom the Division of Radiology (F.M., T.O., S.-i.K., Y.S., M.T., S.F., T.K.), Department of Pathophysiological Therapeutic Science
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Fujii
aFrom the Division of Radiology (F.M., T.O., S.-i.K., Y.S., M.T., S.F., T.K.), Department of Pathophysiological Therapeutic Science
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Kaminou
aFrom the Division of Radiology (F.M., T.O., S.-i.K., Y.S., M.T., S.F., T.K.), Department of Pathophysiological Therapeutic Science
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

REFERENCES

  1. 1.↵
    1. Pahwa R,
    2. Lyons KE
    . Early diagnosis of Parkinson's disease: recommendations from diagnostic clinical guidelines. Am J Manag Care 2010;16(Suppl):S94–99
    PubMedWeb of Science
  2. 2.↵
    1. Fedorow H,
    2. Tribl F,
    3. Halliday G,
    4. et al
    . Neuromelanin in human dopamine neurons; comparison with peripheral melanins and relevance to Parkinson's disease. Prog Neurobiol 2005;75:109–24
    CrossRefPubMedWeb of Science
  3. 3.↵
    1. Zecca L,
    2. Tampellini D,
    3. Gerlach M,
    4. et al
    . Substantia nigra neuromelanin: structure, synthesis, and molecular behavior. Mol Pathol 2001;54:414–18
    Abstract/FREE Full Text
  4. 4.↵
    1. Damier P,
    2. Hirsch EC,
    3. Agid Y,
    4. et al
    . The substantia nigra of the human brain, II: patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999;122:1437–48
    Abstract/FREE Full Text
  5. 5.↵
    1. Fearnley JM,
    2. Lees AJ
    . Aging and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283–301
    Abstract/FREE Full Text
  6. 6.↵
    1. Halliday GM,
    2. McRitchie DA,
    3. Cartwright HR,
    4. et al
    . Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease. J Clin Neurosci 1996;3:52–60
    CrossRefPubMedWeb of Science
  7. 7.↵
    1. Förstl H,
    2. Burns A,
    3. Luthert P,
    4. et al
    . Clinical and neuropathological correlates of depression in Alzheimer's disease. Psychol Med 1992;22:877–84
    PubMedWeb of Science
  8. 8.↵
    1. Sasaki M,
    2. Shibata E,
    3. Tohyama K,
    4. et al
    . Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. NeuroReport 2006;17:1215–18
    CrossRefPubMedWeb of Science
  9. 9.↵
    1. Mann DM,
    2. Yates PO
    . Possible role of neuromelanin in the pathogenesis of Parkinson's disease. Mech Ageing Dev 1983;21:193–203
    CrossRefPubMedWeb of Science
  10. 10.↵
    1. Schwarz ST,
    2. Rittman T,
    3. Gontu V,
    4. et al
    . T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease. Mov Disord 2011;26:1633–38
    CrossRefPubMed
  11. 11.↵
    1. Kashihara K,
    2. Shinya T,
    3. Higaki F
    . Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease. J Clin Neurosci 2011;18:1093–96
    CrossRefPubMed
  12. 12.↵
    1. Wieland DM,
    2. Brown LE,
    3. Rogers WL,
    4. et al
    . Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981;22:22–31
    Abstract/FREE Full Text
  13. 13.↵
    1. Druschky A,
    2. Hilz MJ,
    3. Platsch G,
    4. et al
    . Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci 2000;175:3–12
    CrossRefPubMedWeb of Science
  14. 14.↵
    1. Spiegel J,
    2. Hellwig D,
    3. Farmakis G,
    4. et al
    . Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease. Mov Disord 2007;22:1004–08
    CrossRefPubMedWeb of Science
  15. 15.↵
    1. Hoehn MM,
    2. Yahr MD
    . Parkinsonism: onset, progression and mortality. Neurology 1967;17:427–42
    CrossRefPubMed
  16. 16.↵
    1. Imai Y,
    2. Hasegawa K
    . The revised Hasegawa's dementia scale (HDS-R) - evaluation of its usefulness as a screening test for dementia. J Hong Kong Coll Psychiatr 1994;4:20–24
  17. 17.↵
    1. Tanabe Y,
    2. Harada H,
    3. Sugihara S,
    4. et al
    . 123I-metaiodobenzylguanidine myocardial scintigraphy in panic disorder. J Nucl Med 2004;45:1305–08
    Abstract/FREE Full Text
  18. 18.↵
    1. Tanaka M,
    2. Aihara Y,
    3. Ikeda S,
    4. et al
    . Neuromelanin-related contrast in the substantia nigra semiquantitatively evaluated by magnetic resonance imaging at 3T: comparison between normal aging and Parkinson disease. Clin Neurol 2011;51:14–20
  19. 19.↵
    1. Braak H,
    2. Del Tredici K,
    3. Rub U,
    4. et al
    . Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197–211
    CrossRefPubMedWeb of Science
  20. 20.↵
    1. Halliday GM,
    2. Ophof A,
    3. Broe M,
    4. et al
    . α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Brain 2005;128:2654–64
    Abstract/FREE Full Text
  21. 21.↵
    1. Isaias IU,
    2. Marotta G,
    3. Pezzoli G,
    4. et al
    . Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease. BMC Neurol 2011;11:88
    CrossRefPubMed
  22. 22.↵
    1. Rommelfanger KS,
    2. Weinshenker D
    . Norepinephrine: the redheaded stepchild of Parkinson's disease. Biochem Pharmacol 2007;74:177–90
    CrossRefPubMedWeb of Science
  23. 23.↵
    1. Weinshenker D
    . Functional consequences of locus coeruleus degeneration in Alzheimer's disease. Curr Alzheimer Res 2008;5:342–45
    CrossRefPubMedWeb of Science
  24. 24.↵
    1. Haneka MT,
    2. Nadrigny F,
    3. Regen T,
    4. et al
    . Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine. Proc Natl Acad Sci U S A 2010;107:6058–63
    Abstract/FREE Full Text
  25. 25.↵
    1. Busch C,
    2. Bohl J,
    3. Ohm TG
    . Spatial, temporal and numeric analysis of Alzheimer changes in the nucleus ceruleus. Neurobiol Aging. 1997;18:401–06
    CrossRefPubMedWeb of Science
  26. 26.↵
    1. Nakajima K,
    2. Yoshita M,
    3. Matsuo S,
    4. et al
    . Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders. J Nucl Med Mol Imaging 2008;52:378–87
  27. 27.↵
    1. Okada Y,
    2. Ito Y,
    3. Aida J,
    4. et al
    . Lewy bodies in the sinoatrial nodal ganglion: clinicopathological studies. Pathol Int 2004;54:682–87
    CrossRefPubMed
  28. 28.↵
    1. Orimo S,
    2. Takahashi A,
    3. Uchihara T,
    4. et al
    . Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol 2007;17:24–30
    CrossRefPubMedWeb of Science
  29. 29.↵
    1. Rascol O,
    2. Schelosky L
    . 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders. Mov Disord 2009;24(Suppl 2):S732–41
    CrossRefPubMedWeb of Science
  30. 30.↵
    1. Watanabe M,
    2. Takeda T,
    3. Nakamagoe K,
    4. et al
    . Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson's disease. Eur J Neurol 2011;18:1010–13
    CrossRefPubMed
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 34 (11)
American Journal of Neuroradiology
Vol. 34, Issue 11
1 Nov 2013
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of Parkinson Disease and Alzheimer Disease with the Use of Neuromelanin MR Imaging and 123I-Metaiodobenzylguanidine Scintigraphy
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
F. Miyoshi, T. Ogawa, S.-i. Kitao, M. Kitayama, Y. Shinohara, M. Takasugi, S. Fujii, T. Kaminou
Evaluation of Parkinson Disease and Alzheimer Disease with the Use of Neuromelanin MR Imaging and 123I-Metaiodobenzylguanidine Scintigraphy
American Journal of Neuroradiology Nov 2013, 34 (11) 2113-2118; DOI: 10.3174/ajnr.A3567

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Evaluation of Parkinson Disease and Alzheimer Disease with the Use of Neuromelanin MR Imaging and 123I-Metaiodobenzylguanidine Scintigraphy
F. Miyoshi, T. Ogawa, S.-i. Kitao, M. Kitayama, Y. Shinohara, M. Takasugi, S. Fujii, T. Kaminou
American Journal of Neuroradiology Nov 2013, 34 (11) 2113-2118; DOI: 10.3174/ajnr.A3567
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABREVIATIONS:
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • Acknowledgments
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Age-related differences in Rostral-Middle Locus Coeruleus Microstructure: A Critical Role in Cognitive Decline Revealed by Magnetic Resonance Relaxometry
  • Histology-guided MRI segmentation of brainstem nuclei critical to consciousness
  • Locus coeruleus integrity is related to tau burden and memory loss in autosomal-dominant Alzheimers disease
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Usefulness of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson Disease
  • White Matter Alterations in the Brains of Patients with Active, Remitted, and Cured Cushing Syndrome: A DTI Study
  • Qualitative and Quantitative Analysis of MR Imaging Findings in Patients with Middle Cerebral Artery Stroke Implanted with Mesenchymal Stem Cells
Show more Brain

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire